WMSA
FBIO icon

Weiss Multi-Strategy Advisers’s Fortress Biotech FBIO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-4,193
Closed -$165K – 1008
2013
Q4 		$165K Buy
+4,193
New +$162K ﹤0.01% 924

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return

Weiss Multi-Strategy Advisers's FBIO Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of Fortress Biotech (FBIO) in Q1 2014, closing a stake of 4,193 shares — an estimated $165K sold.

Weiss Multi-Strategy Advisers first reported a position in FBIO in Q4 2013 and held it in 1 quarter. The position peaked at $165K in Q4 2013. 57 funds tracked by Wall St. Rank hold FBIO as of Q1 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Fortress Biotech position as of Q1 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 4,193 Fortress Biotech shares in Q1 2014, an estimated $165K.
  • Weiss Multi-Strategy Advisers first reported a position in Fortress Biotech in Q4 2013 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Fortress Biotech position peaked at $165K in Q4 2013.
  • 57 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.